gvtcx

FCT - Sonata Ablation Device -Women and Children

University Hospitals Sussex NHS Foundation Trust Published 11 Jun 2026 Find a Tender

key details

Statuscomplete
Proceduredirect
SME suitableYes
OCIDocds-h6vhtk-068594

Award

SupplierValueDateStatus
HOLOGIC LTD. £189,850 · cancelled

description

The Trust intends to directly award a contract for the supply, installation, training, and ongoing support of the Sonata® Transcervical Fibroid Ablation System for the treatment of uterine fibroids. The Sonata® Ablation System is a proprietary, integrated medical device protected by intellectual property and exclusive rights held by Hologic. The device is used for the treatment of uterine fibroids. There are no reasonable alternative products available on the market.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
17 Apr 2026 Transparency notice (UK5) Procurement Act 2023 035323-2026
11 Jun 2026 Procurement termination (UK12) Procurement Act 2023 055219-2026

more from University Hospitals Sussex NHS Foundation Trust

all contracts from this buyer →

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.